{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["CXCL12", "CXCR4", "colon cancer", "invasion", "metastasis", "onbaekwon"]], "OtherID": [], "CitationSubset": ["IM"], "InvestigatorList": [], "SpaceFlightMission": [], "GeneralNote": [], "OtherAbstract": [], "PMID": "27160279", "DateCompleted": {"Year": "2018", "Month": "03", "Day": "06"}, "DateRevised": {"Year": "2018", "Month": "11", "Day": "13"}, "Article": {"ArticleDate": [{"Year": "2016", "Month": "05", "Day": "09"}], "ELocationID": ["10.1177/1534735416645182"], "Language": ["eng"], "Journal": {"ISSN": "1552-695X", "JournalIssue": {"Volume": "16", "Issue": "2", "PubDate": {"Year": "2017", "Month": "Jun"}}, "Title": "Integrative cancer therapies", "ISOAbbreviation": "Integr Cancer Ther"}, "ArticleTitle": "Onbaekwon Suppresses Colon Cancer Cell Invasion by Inhibiting Expression of the CXC Chemokine Receptor 4.", "Pagination": {"StartPage": "244", "EndPage": "251", "MedlinePgn": "244-251"}, "Abstract": {"AbstractText": ["Cysteine X cysteine (CXC) chemokine receptor 4 (CXCR4) and C-X-C motif chemokine 12 (CXCL12) were originally identified as chemoattractants between immune cells and sites of inflammation. Since studies have validated an increased level of CXCL12 and its receptor in patients with colorectal cancers, CXCL12/CXCR4 axis has been considered as a valuable marker of cancer metastasis. Therefore, identification of CXCR4 inhibitors has great potential to abrogate tumor metastasis. Onbaekwon (OBW) is a complex herbal formula that is derived from the literature of traditional Korean medicine Dongeuibogam. In this study, we demonstrated that OBW suppressed CXCR4 expression in various cancer cell types in a concentration- and time-dependent manner. Both proteasomal and lysosomal inhibitors had no effect to prevent the OBW-induced suppression of CXCR4, suggesting that the inhibitory effect of OBW was not due to proteolytic degradation but occurred at the transcriptional level. Electrophoretic mobility shift assay further confirmed that OBW could block endogenous activation of nuclear factor kappa B, a key transcription factor that regulates the expression of CXCR4 in colon cancer cells. Consistent with the aforementioned molecular basis, OBW abolished cell invasion induced by CXCL12 in colon cancer cells. Together, our results suggest that OBW, as a novel inhibitor of CXCR4, could be a promising therapeutic agent contributing to cancer treatment."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "1 Keimyung University, Daegu, South Korea."}], "LastName": "Kim", "ForeName": "Buyun", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "1 Keimyung University, Daegu, South Korea."}], "LastName": "Yoon", "ForeName": "Jaewoo", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "2 Kyung Hee University Hospital at Gangdong, Seoul, Korea."}], "LastName": "Yoon", "ForeName": "Seong Woo", "Initials": "SW"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "1 Keimyung University, Daegu, South Korea."}], "LastName": "Park", "ForeName": "Byoungduck", "Initials": "B"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Integr Cancer Ther", "NlmUniqueID": "101128834", "ISSNLinking": "1534-7354"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents, Phytogenic"}, {"RegistryNumber": "0", "NameOfSubstance": "CXCR4 protein, human"}, {"RegistryNumber": "0", "NameOfSubstance": "Chemokine CXCL12"}, {"RegistryNumber": "0", "NameOfSubstance": "NF-kappa B"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "0", "NameOfSubstance": "Receptors, CXCR4"}], "MeshHeadingList": [{"QualifierName": ["pharmacology"], "DescriptorName": "Antineoplastic Agents, Phytogenic"}, {"QualifierName": [], "DescriptorName": "Cell Line, Tumor"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Movement"}, {"QualifierName": ["antagonists & inhibitors"], "DescriptorName": "Chemokine CXCL12"}, {"QualifierName": ["drug effects", "metabolism"], "DescriptorName": "Colon"}, {"QualifierName": ["drug therapy", "metabolism"], "DescriptorName": "Colonic Neoplasms"}, {"QualifierName": ["drug effects"], "DescriptorName": "Gene Expression Regulation, Neoplastic"}, {"QualifierName": [], "DescriptorName": "HCT116 Cells"}, {"QualifierName": [], "DescriptorName": "Hep G2 Cells"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["methods"], "DescriptorName": "Medicine, Korean Traditional"}, {"QualifierName": ["metabolism"], "DescriptorName": "NF-kappa B"}, {"QualifierName": ["pathology"], "DescriptorName": "Neoplasm Invasiveness"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Plant Extracts"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["antagonists & inhibitors"], "DescriptorName": "Receptors, CXCR4"}], "CoiStatement": "<b>Declaration of Conflicting Interest:</b> The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65:87-108.", "ArticleIdList": ["25651787"]}, {"Citation": "Balkwill FR. The chemokine system and cancer. J Pathol. 2012;226:148-157.", "ArticleIdList": ["21989643"]}, {"Citation": "Burger JA, Kipps TJ. CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment. Blood. 2006;107:1761-1767.", "ArticleIdList": ["16269611"]}, {"Citation": "Oppenheim JJ, Zachariae CO, Mukaida N, Matsushima K. Properties of the novel proinflammatory supergene \u201cintercrine\u201d cytokine family. Annu Rev Immunol. 1991;9:617-648.", "ArticleIdList": ["1910690"]}, {"Citation": "Salvucci O, Bouchard A, Baccarelli A, et al. The role of CXCR4 receptor expression in breast cancer: a large tissue microarray study. Breast Cancer Res Treat. 2006;97:275-283.", "ArticleIdList": ["16344916"]}, {"Citation": "Newman DJ, Cragg GM. Natural products as sources of new drugs over the 30 years from 1981 to 2010. J Nat Prod. 2012;75:311-335.", "ArticleIdList": ["PMC3721181", "22316239"]}, {"Citation": "Bak EJ, Park HG, Kim JM, Kim JM, Yoo YJ, Cha JH. Inhibitory effect of evodiamine alone and in combination with rosiglitazone on in vitro adipocyte differentiation and in vivo obesity related to diabetes. Int J Obes (Lond). 2010;34:250-260.", "ArticleIdList": ["19859078"]}, {"Citation": "Xue L, Zhang HY, Qin L, Wang XC, Wang L. Effect of chuanwu and baishao used separately or in combination on adjuvant arthritis in rats [in Chinese]. Zhongguo Zhong Yao Za Zhi. 2000;25:175-178.", "ArticleIdList": ["12212105"]}, {"Citation": "Hikino H, Konno C, Takata H, et al. Antiinflammatory principles of Aconitum roots. J Pharmacobiodyn. 1980;3:514-525.", "ArticleIdList": ["7205533"]}, {"Citation": "Pak KC, Lam KY, Law S, Tang JC. The inhibitory effect of Gleditsia sinensis on cyclooxygenase-2 expression in human esophageal squamous cell carcinoma. Int J Mol Med. 2009;23:121-129.", "ArticleIdList": ["19082515"]}, {"Citation": "Tang WK, Chui CH, Fatima S, et al. Inhibitory effects of Gleditsia sinensis fruit extract on telomerase activity and oncogenic expression in human esophageal squamous cell carcinoma. Int J Mol Med. 2007;19:953-960.", "ArticleIdList": ["17487429"]}, {"Citation": "Murakami T, Kawada K, Iwamoto M, et al. The role of CXCR3 and CXCR4 in colorectal cancer metastasis. Int J Cancer. 2013;132:276-287.", "ArticleIdList": ["22689289"]}, {"Citation": "Zhao H, Guo L, Zhao H, Zhao J, Weng H, Zhao B. CXCR4 over-expression and survival in cancer: a system review and meta-analysis. Oncotarget. 2015;6:5022-5040.", "ArticleIdList": ["PMC4467131", "25669980"]}, {"Citation": "Sun Y, Mao X, Fan C, et al. CXCL12-CXCR4 axis promotes the natural selection of breast cancer cell metastasis. Tumour Biol. 2014;35:7765-7773.", "ArticleIdList": ["PMC4158177", "24810923"]}, {"Citation": "Fernandis AZ, Cherla RP, Chernock RD, Ganju RK. CXCR4/CCR5 down-modulation and chemotaxis are regulated by the proteasome pathway. J Biol Chem. 2002;277:18111-18117.", "ArticleIdList": ["11877445"]}, {"Citation": "Marchese A, Benovic JL. Agonist-promoted ubiquitination of the G protein-coupled receptor CXCR4 mediates lysosomal sorting. J Biol Chem. 2001;276:45509-45512.", "ArticleIdList": ["11641392"]}, {"Citation": "Bhandari D, Trejo J, Benovic JL, Marchese A. Arrestin-2 interacts with the ubiquitin-protein isopeptide ligase atrophin-interacting protein 4 and mediates endosomal sorting of the chemokine receptor CXCR4. J Biol Chem. 2007;282:36971-36979.", "ArticleIdList": ["17947233"]}, {"Citation": "Matsusue R, Kubo H, Hisamori S, et al. Hepatic stellate cells promote liver metastasis of colon cancer cells by the action of SDF-1/CXCR4 axis. Ann Surg Oncol. 2009;16:2645-2653.", "ArticleIdList": ["19588204"]}, {"Citation": "Moyer RA, Wendt MK, Johanesen PA, Turner JR, Dwinell MB. Rho activation regulates CXCL12 chemokine stimulated actin rearrangement and restitution in model intestinal epithelia. Lab Invest. 2007;87:807-817.", "ArticleIdList": ["PMC2693067", "17572689"]}, {"Citation": "Balkwill F. The significance of cancer cell expression of the chemokine receptor CXCR4. Semin Cancer Biol. 2004;14:171-179.", "ArticleIdList": ["15246052"]}, {"Citation": "Ramsey DM, McAlpine SR. Halting metastasis through CXCR4 inhibition. Bioorg Med Chem Lett. 2013;23:20-25.", "ArticleIdList": ["23211868"]}, {"Citation": "Furusato B, Mohamed A, Uhlen M, Rhim JS. CXCR4 and cancer. Pathol Int. 2010;60:497-505.", "ArticleIdList": ["20594270"]}, {"Citation": "Salvucci O, Yao L, Villalba S, Sajewicz A, Pittaluga S, Tosato G. Regulation of endothelial cell branching morphogenesis by endogenous chemokine stromal-derived factor-1. Blood. 2002;99:2703-2711.", "ArticleIdList": ["11929756"]}, {"Citation": "Ahn JY, Seo K, Weinberg OK, Arber DA. The prognostic value of CXCR4 in acute myeloid leukemia. Appl Immunohistochem Mol Morphol. 2013;21:79-84.", "ArticleIdList": ["22914607"]}, {"Citation": "Porcile C, Bajetto A, Barbero S, Pirani P, Schettini G. CXCR4 activation induces epidermal growth factor receptor transactivation in an ovarian cancer cell line. Ann N Y Acad Sci. 2004;1030:162-169.", "ArticleIdList": ["15659794"]}, {"Citation": "Proudfoot AE. Chemokine receptors: multifaceted therapeutic targets. Nat Rev Immunol. 2002;2:106-115.", "ArticleIdList": ["PMC7097668", "11910892"]}, {"Citation": "Gschwind A, Prenzel N, Ullrich A. Lysophosphatidic acid-induced squamous cell carcinoma cell proliferation and motility involves epidermal growth factor receptor signal transactivation. Cancer Res. 2002;62:6329-6336.", "ArticleIdList": ["12414665"]}, {"Citation": "Kulbe H, Hagemann T, Szlosarek PW, Balkwill FR, Wilson JL. The inflammatory cytokine tumor necrosis factor-alpha regulates chemokine receptor expression on ovarian cancer cells. Cancer Res. 2005;65:10355-10362.", "ArticleIdList": ["16288025"]}, {"Citation": "Bachelder RE, Wendt MA, Mercurio AM. Vascular endothelial growth factor promotes breast carcinoma invasion in an autocrine manner by regulating the chemokine receptor CXCR4. Cancer Res. 2002;62:7203-7206.", "ArticleIdList": ["12499259"]}, {"Citation": "Bohonowych JE, Hance MW, Nolan KD, Defee M, Parsons CH, Isaacs JS. Extracellular Hsp90 mediates an NF-kappaB dependent inflammatory stromal program: implications for the prostate tumor microenvironment. Prostate. 2014;74:395-407.", "ArticleIdList": ["PMC4306584", "24338924"]}, {"Citation": "Helbig G, Christopherson KW, 2nd, Bhat-Nakshatri P, et al. NF-kappaB promotes breast cancer cell migration and metastasis by inducing the expression of the chemokine receptor CXCR4. J Biol Chem. 2003;278:21631-21638.", "ArticleIdList": ["12690099"]}, {"Citation": "Zhi Y, Duan Y, Zhou X, et al. NF-kappaB signaling pathway confers neuroblastoma cells migration and invasion ability via the regulation of CXCR4. Med Sci Monit. 2014;20:2746-2752.", "ArticleIdList": ["PMC4280060", "25527973"]}, {"Citation": "Cho JS, Han IH, Lee HR, Lee HM. Prostaglandin E2 induces IL-6 and IL-8 production by the EP receptors/Akt/NF-kappaB pathways in nasal polyp-derived fibroblasts. Allergy Asthma Immunol Res. 2014;6:449-457.", "ArticleIdList": ["PMC4161687", "25229003"]}, {"Citation": "Shibata A, Nagaya T, Imai T, Funahashi H, Nakao A, Seo H. Inhibition of NF-kappaB activity decreases the VEGF mRNA expression in MDA-MB-231 breast cancer cells. Breast Cancer Res Treat. 2002;73:237-243.", "ArticleIdList": ["12160329"]}, {"Citation": "Kukreja P, Abdel-Mageed AB, Mondal D, Liu K, Agrawal KC. Up-regulation of CXCR4 expression in PC-3 cells by stromal-derived factor-1alpha (CXCL12) increases endothelial adhesion and transendothelial migration: role of MEK/ERK signaling pathway-dependent NF-kappaB activation. Cancer Res. 2005;65:9891-9898.", "ArticleIdList": ["16267013"]}, {"Citation": "Song ZY, Gao ZH, Chu JH, Han XZ, Qu XJ. Downregulation of the CXCR4/CXCL12 axis blocks the activation of the Wnt/beta-catenin pathway in human colon cancer cells. Biomed Pharmacother. 2015;71:46-52.", "ArticleIdList": ["25960214"]}], "ReferenceList": []}], "History": [{"Year": "2016", "Month": "5", "Day": "11", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "3", "Day": "7", "Hour": "6", "Minute": "0"}, {"Year": "2016", "Month": "5", "Day": "11", "Hour": "6", "Minute": "0"}, {"Year": "2016", "Month": "5", "Day": "9"}], "PublicationStatus": "ppublish", "ArticleIdList": ["27160279", "PMC5739121", "10.1177/1534735416645182", "1534735416645182"]}}], "PubmedBookArticle": []}